These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1501739)

  • 1. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
    St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
    Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
    Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
    Messa P; Mioni G; Turrin D; Guerra UP
    Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
    Portale AA; Booth BE; Halloran BP; Morris RC
    J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
    Rudnicki M; McNair P; Transbøl I; Nielsen B
    Nephron; 1991; 58(2):144-9. PubMed ID: 1865969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).
    Combe C; Morel D; de Précigout V; Blanchetier V; Bouchet JL; Potaux L; Fournier A; Aparicio M
    Nephron; 1995; 70(3):287-95. PubMed ID: 7477615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration.
    Takamoto S; Onishi T; Morimoto S; Imanaka S; Tsuchiya H; Seino Y; Yokokawa T; Iida N; Kumahara Y
    Nephron; 1985; 40(3):286-91. PubMed ID: 3839293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelationship between serum concentrations of 1,25-dihydroxyvitamin D, parathyroid hormone and renal haemodynamics after low dose cyclosporin.
    Edwards BD; Davies M; Mawer EB; Chalmers RJ; Testa HJ; Ballardie FW
    Miner Electrolyte Metab; 1994; 20(5):250-4. PubMed ID: 7700211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
    Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
    Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
    Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients.
    Messa P; Vallone C; Mioni G; Geatti O; Turrin D; Passoni N; Cruciatti A
    Kidney Int; 1994 Dec; 46(6):1713-20. PubMed ID: 7700031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal insufficiency and secondary hyperparathyroidism in elderly patients.
    Turner G; Brown RC; Silver A; Seymour G; Woodhead JS
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():321-6. PubMed ID: 1892341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
    Portale AA; Morris RC
    Miner Electrolyte Metab; 1991; 17(4):211-20. PubMed ID: 1813783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?
    Frølich A; Storm T; Thode J
    Miner Electrolyte Metab; 1996; 22(4):203-6. PubMed ID: 8807622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.